Phocas Financial’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-135,392
Closed -$3.33M – 51
2026
Q2
$3.33M Sell
135,392
-7,129
-5% -$165K 0.46% 95
2026
Q1
$3.41M Sell
142,521
-40,234
-22% -$984K 0.54% 78
2025
Q4
$4.14M Sell
182,755
-37,204
-17% -$810K 0.54% 75
2025
Q3
$4.43M Buy
219,959
+4,521
+2% +$75.7K 0.57% 73
2025
Q2
$3.08M Buy
215,438
+32
+0% +$374 0.44% 89
2025
Q1
$2.26M Sell
215,406
-12,218
-5% -$138K 0.35% 102
2024
Q4
$2.76M Buy
+227,624
New +$2.98M 0.37% 104
2023
Q4
$3.86M Buy
+258,869
New +$2.93M 0.51% 87

Other funds holding ELAN

Phocas Financial's ELAN Position: Q3 2026 in Review

Phocas Financial sold out of Elanco Animal Health (ELAN) in Q3 2026, closing a stake of 135,392 shares — an estimated $3.33M sold.

Phocas Financial first reported a position in ELAN in Q4 2023 and held it in 8 quarters. The position peaked at $4.43M in Q3 2025. 423 funds tracked by Wall St. Rank hold ELAN as of Q3 2026.

  • Phocas Financial reported no remaining Elanco Animal Health position as of Q3 2026 after selling out during the quarter.
  • Phocas Financial sold 135,392 Elanco Animal Health shares in Q3 2026, an estimated $3.33M.
  • Phocas Financial first reported a position in Elanco Animal Health in Q4 2023 and held it in 8 quarters.
  • Phocas Financial's Elanco Animal Health position peaked at $4.43M in Q3 2025.
  • 423 funds tracked by Wall St. Rank held Elanco Animal Health as of Q3 2026.

Based on Phocas Financial's 13F filing for Q3 2026.